FEBS Open Bio (Apr 2023)

The breast cancer microenvironment and lipoprotein lipase: Another negative notch for a beneficial enzyme?

  • Makayla M. Bavis,
  • Allison M. Nicholas,
  • Alexandria J. Tobin,
  • Sherri L. Christian,
  • Robert J. Brown

DOI
https://doi.org/10.1002/2211-5463.13559
Journal volume & issue
Vol. 13, no. 4
pp. 586 – 596

Abstract

Read online

The energy demand of breast cancers is in part met through the β‐oxidation of exogenous fatty acids. Fatty acids may also be used to aid in cell signaling and toward the construction of new membranes for rapidly proliferating tumor cells. A significant quantity of fatty acids comes from the hydrolysis of lipoprotein triacylglycerols and phospholipids by lipoprotein lipase (LPL). The lipid obtained via LPL in the breast tumor microenvironment may thus promote breast tumor growth and development. In this hypothesis article, we introduce LPL, provide a meta‐analysis of RNAseq data showing that LPL is associated with poor prognosis, and explain how LPL might play a role in breast cancer prognosis over time.

Keywords